Jerome S. Fischer, M.D.

Biography

Dr. Fischer is a Board-Certified Endocrinologist, specializing in Internal Medicine with an expertise in several areas, including Type 2 diabetes mellitus, adult obesity, diseases of the pituitary and the thyroid glands.  He is a highly experienced physician with more than 35 years in the field of Endocrinology/Diabetes/Metabolism, both in private practice and in research.  After receiving his Bachelor of Science, Magna Cum Laude, from the University of Pennsylvania in 1973, he received his medical degree from the highly rated Thomas Jefferson University Medical School in 1977.  He completed his Fellowship in Endocrinology at George Washington University Medical Center in 1982. 

He joined the Diabetes & Glandular Disease Clinic in San Antonio, Texas as first partner in July 1982.  He is highly regarded by his patients, and is the recipient of numerous awards.  He is a published author and lecturer, having numerous articles in peer-reviewed journals.  Accomplished in the field of research, Dr. Fischer has served on several Advisory Boards, most recently Glooko, Inc.  He has been an Adjunct Associate Professor/Clinical Instructor of Medicine/Endocrinology for the University of Texas Health Science Center at San Antonio for numerous years, and is an active member of several esteemed professional groups, including the American Association of Clinical Endocrinologists, The American Diabetes Association, and The Endocrine Society, to name a few.

Dr. Fischer has raised awareness for people with intellectual disabilities by sponsoring and encouraging his clinic employees and their families to participate in various 5K Walks & Runs.  He has a keen interest in the expanding technology of diabetes care, including cloud-based systems, and looks forward to digital health solutions changing the face of chronic  disease management for patients living with chronic diseases such as diabetes. He and his partners at DGD Clinic  are excited about the new FDA-approved smart phone apps that titrate, or make continuous insulin adjustments for patients with Type 1 and Type 2 diabetes.  Equally exciting for the clinic is the arrival of a new, groundbreaking hybrid closed loop insulin pump. This groundbreaking technology will simplify and improve diabetes management with the use of smart algorithms, resulting in greater glucose control with reduced user input. 

Education

Fellowship in Endocrinology, George Washington University Medical Center, Washington, DC, 1982

Residency, Internal Medicine, Long Island Jewish Hillside Medical Center, 1978 - 1980

Internship, Long Island Jewish - Hillside Medical Center, 1977 - 1978

M.D., Thomas Jefferson Medical School, Philadelphia, Pennsylvania, 1973 - 1977

Bachelor of Science, Magna Cum Laude, University of Pennsylvania, Philadelphia, PA, 1969 - 1973

Licenses

Texas Medical License – active since 1983

Board Certification

Fellow (FACE) American Association of Clinical Endocrinology

American Board of Internal Medicine 

American Board of Internal Medicine Endocrinology and Metabolism

American Association of Clinical Endocrinologists 

American Medical Association

Texas Medical Association

The Endocrine Society

Vertical Tabs

Employment History

Employment History

July 1982 to present - Diabetes and Glandular Disease Clinic, P.A. 5107 Medical Drive, San Antonio, Texas 78229

2006 to 2009 – Cetero Research, San Antonio, Texas 78229

July 1982 to 2006 - Diabetes and Glandular Disease Clinic Research Associates, P.A. 5107 Medical Drive, San Antonio, Texas 78229

March 2000 to 2006 - Diabetes and Glandular Disease Clinic Westside Office 803 Castroville Road Suite 140 San Antonio, Texas 78237

Awards & Honors

Awards & Honors

Selected as a Top Endocrinologist in San Antonio, TX by the International Association of HealthCare Professionals (IAHCP) 2015/2016. Spotlighted in the renowned publication, The Leading Physicians of The World.

Physicians Office Systems Recognition™ (POR) Level II 2013 – 2015. Recognizes practices that use Information Systems to enhance the quality of patient care).

Bridges to Excellence® (BTE) Diabetes Care Recognition (DCR). Recognizes and honors physicians who deliver superior care for patients with diabetes.

Recipient Top Ten Doctors in San Antonio, TX 2012

Academic Appointments

Academic Appointments

Fellow of American College Clinical Endocrinology, 1995

Clinical Instructor, University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Endocrinology, 1983 - present

Associate, Department of Medicine, George Washington University Medical Center, 1980 - 1982

Professional Memberships

Professional Memberships

American Medical Informatics Association, 1998 to present

American Society of Internal Medicine, 1996 – present

American Association of Clinical Endocrinologists (AACE), 1993 – present

The Endocrine Society, 1992 – present

Texas Medical Association, 1984 – present

Bexar County Medical Society, 1983 – present

American Diabetes Association, 1981 – present

American Medical Association, 1978 – present

Professional Activities

Professional Activities

Co–Director, Sixth South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1988

Co–Director, 5K Diabetes Run (Humanathon), 1984 - 1987

Co–Director, Fifth South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1987

Co-Director, Fourth Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1986

Co-Director, Third Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1985

Director, Eating Disorder Unit, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1984 - 1985

Faculty Member, University of Texas Health Center at San Antonio, First Annual Update on Medicine, Laredo, Texas, 1985

Co–Director Second Bi – Annual South Texas Clinical Diabetes Symposium, San Antonio, Texas, 1983

Co–Director, Diabetes Center of Excellence, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1983 - present

Co-Director, Diabetes and Glandular Disease Clinic, San Antonio, Texas, 1982 - present

Coordinator of Young Adult Week at Camp Glyndon, Camp for Children with Diabetes Mellitus, 1982

Advisory Board, Diabetes Center of Excellence, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), 1982 - present

Member, MD Team at Camp Glyndon, Camp for Children with Diabetes Mellitus, 1980 - 1981

Chairman, Department of Medicine, Methodist Specialty & Transplant Hospital (formerly San Antonio Community Hospital), San Antonio, Texas

Lectures

Lectures

Microsoft Health Users Group – Windows on Health Care, October 12, 1998

Speakers’ Program, Nursing Education Satellite Network - Diabetes: DCCT, Video Conference and videotapes, April, 1995

Speakers’ Program, Parke-Davis, 1988 - present

Speakers’ Program, Bristol-Myers Squibb, 1988 - present

Speakers’ Program, Merck & Co., Inc., 1988 - present

Speakers’ Program, Pfizer, Inc., 1984 - present

Speakers’ Program, Eli Lilly, 1983 - present

Town Hall Meetings (Diabetes Mellitus Updates), Midland, Texas, 1983

Town Hall Meetings (Diabetes Mellitus Updates), San Antonio, Texas, 1983

Federal Aviation Medical Seminar, 1983 - 1984

Pharmacy Series, San Antonio, Texas, 1984

Pharmacy Series, H.E.B. Pharmacists of Texas, 1984

Eli Lilly Postgraduate Lecture Series, San Antonio Pharmacists, 1983

Midland Memorial, Midland, Texas, 1983

Odessa Medical Center, Odessa, Texas, 1983

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump, Second Generation Oral Hypoglycemic Agents, Victoria Hospital, Victoria, Texas, 1983

St. Agnes Hospital, Fond du lac, Wisconsin, 1983

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump, Second Generation Oral Hypoglycemic Agents, Frio Hospital, Frio, Texas, 1982

Speakers’ Program, Diabetes Mellitus, Type I and Type II, New Insulin, Insulin Pump, Second

Generation Oral Hypoglycemic Agents, Education Service Center, Region 20, 1982

Teleconference network of Texas

Teleconference network of Texas

Diabetes and Diet, 1989

Diabetes - New Pharmacology, 1986

Insulin and Insulin Delivery, 1986

Osteoporosis, 1986

Management of Diabetes Mellitus, April 1985

Treatment Aspects of Severe Anorexia and Bulimia, November 1984

Publications

Publications

mHealth Enabled Remote Monitoring Improves Diabetes Outcomes.  Vikram Singh; Reid Offringa, Ph.D.; Tanushree Bose, PhD; Michael Greenfield, MD; Jerome S. Fischer, MD.  Diabetes & Glandular Disease Clinic.  Diabetes Technology Meeting, Bethesda MA, USA October 22-24, 2015. 

Impact of Achieved Systolic Blood Pressure On Renal Function In Type 2 Diabetic Nephropathy. Marc A. Pohl, MD1; Samuel Blumenthal, MD2; Lawrence G. Hunsicker, MD3 and The Collaborative Study Group4.(Jerome S. Fischer), San Antonio, TX ; 1Cleveland Clinic Fdn., Cleveland Ohio; 2Veterans Administration, Milwaukee, Wisconsin; 3University of Iowa Hospitals and Clinics, Iowa City, Iowa and 4Rush Medical College, Chicago, Illinois. Diabetes Technology Meeting, Bethesda MA, USA October 22-24, 2015.

Diabetes Care Documentation & Coding For Clinicians.  Jerome S. Fischer, M.D. ã2002 by the American Diabetes Association, Inc.  Professional Books.  Library of Congress Cataloging-in-Publication Data.

Abstracts

Abstracts

Sensor-Augmented Insulin Pump Therapy; Results of The First Randomized Treat-to-Target Study.  Hirsch IB, Abelseth, J, Bode, BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA,  Buckingham BA.  Diabetes Technol Ther. 2008 Oct; 10(5):377-83

Double-Blind, Placebo-Controlled Trial of Islet Neogenesis Gene Associated Protein (INGAP) Therapy in Type 2 Diabetes (T2 DM) Subjects.    R.E. RATNER, D. FEELEY, J. B. BUSE, J. S. FISCHER.  Institutions:  Washington, DC;  Chapel Hill, NC; San Antonio, TX.    Scientific Sessions – A.D.A. Annual Meeting – American Diabetes Association 2005.   Abstract Number:  12-LB

Vardenafil Increases the Percent of Patients Achieving Initial SEP2/SEP3 Success by the 3rd Attempt in Diabetic Men with Erectile Dysfunction.   JEROME FISCHER, JAY YOUNG, JEAN-FRANCOIS YALE, MARTIN HOMERING, TERRY TAYLOR, IRWIN GOLDSTEIN.  Institutions:  San Antonio, TX; Laguna Woods, CA; Montreal QC, Canada; Wuppertal, Germany; West Haven, CT; Boston, MA.    Scientific Sessions – A.D.A. Annual Meeting – American Diabetes Association 2004.   Abstract Number:  110-OR

Achievement of Glycemic Goal and Durability of Glycemia Control with Use of TZDs.   JEROME FISCHER, RIAD DIRANI, M. COLLEEN O; NEILL, ALAN BAKST.  Institutions:  San Antonio, TX; Philadelphia, PA; King of Prussia, PA.    Scientific Sessions – A.D.A. Annual Meeting – American Diabetes Association 2004.   Abstract Number:  1987-PO. 

Improvements in Quality of Life in Diabetic Patients Following Initiation of Insulin Glargine Therapy in Clinical Practice Setting.  JEROME S. FISCHER, CRAIG S. ROBERTS, TRENT MCLAUGHLIN, LITZA LOZA, REBECCA BEAUCHAMP, LAURA ANTELL, SHERWYN SCHWARTZ, MARK KIPNES.    Institutions:  San Antonio, TX; Yardley, PA; Bridgewater, NJ.    Scientific Sessions – A.D.A. Annual Meeting – American Diabetes Association 2003.   Abstract Number:  1934-PO. 

Poster Presentations

Poster Presentations

mHealth Enabled Remote Monitoring Improves Diabetes Outcomes.  Vikram Singh; Reid Offringa, Ph.D.; Tanushree Bose, Ph.D.; Michael Greenfield, MD; Jerome S. Fischer, MD.  Diabetes & Glandular Disease Clinic.  Diabetes Technology Meeting, Bethesda MA, USA October 22-24, 2015. 

Impact of Achieved Systolic Blood Pressure On Renal Function In Type 2 Diabetic Nephropathy.  Marc A. Pohl, MD1; Samuel Blumenthal, MD2; Lawrence G. Hunsicker, MD3 and The Collaborative Study Group4. 1Cleveland Clinic Fdn., Cleveland Ohio; 2Veterans Administration, Milwaukee, Wisconsin; 3University of Iowa Hospitals and Clinics, Iowa City, Iowa and 4Rush Medical College, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

Impact Of Angiotensin Receptor Blockade With Irbesartan On Renal Function At Different Systolic Blood Pressure (SBP) Levels In Type 2 Diabetic Nephropathy.  Marc A. Pohl, MD1; Daniel J. Cordonnier, MD2; Samuel Spitalewitz, MD3 and The Collaborative Study Group4.  1Cleveland Clinic Foundation, Cleveland Ohio; 2University of Grenoble, Grenoble, France; 3Brooklyn Hospital Medical Center, Brooklyn, NY and 4Rush Medical College, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

The Severity Of Orthostatic Hypotension Is A Risk Factor In The Progression Of Type 2 Diabetic Nephropathy.  Matthew R. Weir, MD and Lawrence G. Hunsicker, MD, for The Collaborative Study Group, Chicago Illinois.  Presented at the ASN Meeting, November 2002. 

The Presence Of Retinopathy Is Associated With Poor Renal And Cardiovascular Outcomes In Type 2 Diabetic Nephropathy.  Roger Rodby, MD1; Richard Gilbert, MD2, for The Collaborative Study Group, 1 Chicago, Illinois USA.  2Victoria, Australia.  Presented at the ASN Meeting, November 2002. 

Predictors Of The Progression Of Renal Insufficiency In Patients With Type 2 Diabetes And Overt Diabetic Nephropathy.  John P. Middleton, Julia Lewis, for The Collaborative Study Group University of Texas Southwestern, Dallas, Texas; Vanderbilt University, Nashville, Tennessee.  Presented at the ASN Meeting, November 2002. 

Cardiovascular Outcomes In The Irbesartan Diabetic Nephropathy Trial (IDNT) Of Patients With Type 2 Diabetes And Overt Nephropathy.  Tomas Berl, MD1 for The Collaborative Study Group2.  1Division of Renal Diseases and Hypertension, University of Colorado2, Denver, Colorado Department of Medicine, Rush Medical Center, Chicago, Illinois.  Presented at the ASN Meeting, November 2002. 

Impact of Use of Insulin, Glargine, on Hbg A1c and BMI in a Specialty (Endocrine) Practice Population.  JEROME S. FISCHER, RIAD G. DIRANI, SHERWYN L. SCHWARTZ, MARK S. KIPNES, FERNANDO W. TRIGOSO, AMNA A. SALHIN, JACOB VADAKEKALAM, DAINA DREIMANE, LITZA LOZA.  San Antonio, TX; Bridgewater, NJ.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Physiologic Differences Between Volar and Dorsal Capillary Forearm Glucose Concentrations and Finger Stick Glucose Concentrations in Diabetics.  STEPHEN L. MONFRE, KEVIN H. HAZEN, JEROME S. FISCHER, MATTHEW WELCH, LINDA HOCKERSMITH, RYAN J. GUTTRIDGE, TIMOTHY L. RUCHTI.  Chandler, AZ; San Antonio, TX.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Influence of HbA1c on the Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Diabetes. IRWIN GOLDSTEIN, JEROME FISCHER, TERRY TAYLOR, MARC THIBONNIER.  Boston, MA; San Antonio, TX; West Haven, CT.  Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62nd Scientific Sessions, June 14 – 18, 2002, Volume 51, Supplement 2.

Research

Research

Clinical Trials Listing available upon request.

Diplomate

Diplomate

American Board of Internal Medicine

American Board of Endocrinology

Honors and Awards

Honors and Awards

Adjunct Associate Professor, Department of Medicine/Endocrinology, University of Texas Health Science Center at San Antonio Texas School of Medicine

Top MD Consumers Checkbook

Super Doctors 2005 – 2017 SuperDoctors.com

Basketball Coach – Special Olympics

Bridges To Excellence Physician Office Systems Recognition (2015, 2016, 2017) 

Bridges To Excellence Diabetes Care Recognition (2015, 2016, 2017)

Vitals On-Time Doctor Award (2014)